Seattle startup Receptor Life Sciences has raised $9.7 million to move its CBD-based therapeutic candidate for acute anxiety through clinical… Read More
— Protein design company Arzeda raised $33 million, the Seattle startup announced Wednesday. The company generates new enzymes for industrial,… Read More
Philip Greenberg has been trying to stop cancer for decades. With Affini-T Therapeutics, the Fred Hutchinson Cancer Research Center investigator… Read More
Seattle-based vaccine company Icosavax posted disappointing clinical data today for its experimental COVID-19 vaccine, sending its stock into a dive.… Read More
Houston-based Karios Technologies won the inaugural Apis Health Angel Conference, launched in Seattle to connect investors and health-related startups. The… Read More
Bothell, Wash.-based Seagen is partnering with Sanofi to design, develop and commercialize experimental drugs for up to three molecular targets… Read More
A self-funded artificial intelligence startup is partnering with Microsoft to address a long-standing problem in the medical field: infections caused… Read More